DUBLIN--(BUSINESS WIRE)--The "Bone Densitometer Market by Type (DEXA, Peripheral), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Body Composition Measurement, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic Centres) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global bone densitometer market is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period.
The axial bone densitometry segment is expected to account for the largest share of the bone densitometer market.
Axial bone densitometers fulfill various requirements of clinicians, which is a major factor driving market growth. These instruments predominantly include central dual-energy X-ray absorptiometry-based tools that are imperative to obtain accurate results in diagnostic procedures. The osteoporosis & osteopenia diagnosis segment is expected to account for the largest share of the bone densitometer market. The osteoporosis & osteopenia diagnosis segment accounted for the largest share of the global bone densitometer market in 2021. Large geriatric population suffering from osteoporosis and increasing risk of osteoporosis in menopausal women are the key factors driving the segment growth. The hospitals & specialty clinics segment is expected to account for the largest share of the bone densitometer market.
The hospitals & specialty clinics segment accounted for the largest share of the global bone densitometer market in 2021. Hospitals have the financial capacity to purchase expensive equipment and have trained professionals who can effectively use bone densitometers. Specialty clinics also use bone densitometers to diagnose various medical conditions, such as osteoporosis and osteopenia, as well as for body mass measurement. Asia Pacific market to witness the highest growth during the forecast period.
The APAC market is estimated to grow at the highest CAGR during the forecast period. Asian countries (particularly China and India) are expected to offer significant growth opportunities for market players during the forecast period, primarily due to the rising geriatric population, increasing incidence of osteoporosis, increasing healthcare expenditure, and the growing number of hospitals and clinics in their respective healthcare systems. Some of the prominent players operating in this market are GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.p.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), and Eurotec Systems S.r.l (Italy). Increasing Prevalence of Osteoporosis to Drive the Market for Bone Densitometers China to Witness the Highest Growth in the Bone Densitometers Market from 2022 to 2027
Asia-Pacific to Register the Highest CAGR During the Forecast Period (2022-2027)
Developing Countries to Register Higher Growth Rates During the Forecast Period
High Cost of Bone Densitometers
Growth Opportunities in Emerging Markets
Lack of Access to Diagnostics
Unfavorable Reimbursement Scenario
Assessment of COVID-19 Impact on the Economic Scenario of the Bone Densitometers Market Eurotec Medical Systems S.R.L.
L'Acn L'Accessorio Nucleare S.R.L
Xianyang Kanrota Digital Ultrasound System, Co., Ltd.
Anjue Medical Equipment Co., Ltd.
Guangzhou Medsinglong Medical Equipment Co., Ltd.
Nanjing Kejin Industrial Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/c4xsy1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.